133 related articles for article (PubMed ID: 37121096)
1. Breath testing for SARS-CoV-2 infection.
Myers R; Ruszkiewicz DM; Meister A; Bartolomeu C; Atkar-Khattra S; Thomas CLP; Lam S
EBioMedicine; 2023 Jun; 92():104584. PubMed ID: 37121096
[TBL] [Abstract][Full Text] [Related]
2. Identification of a characteristic VOCs pattern in the exhaled breath of post-COVID subjects: are metabolic alterations induced by the infection still detectable?
Di Gilio A; Palmisani J; Picciariello A; Zambonin C; Aresta A; De Vietro N; Franchini SA; Ventrella G; Nisi MR; Licen S; Barbieri P; Altomare DF; de Gennaro G
J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37379826
[TBL] [Abstract][Full Text] [Related]
3. Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls.
Woollam M; Angarita-Rivera P; Siegel AP; Kalra V; Kapoor R; Agarwal M
J Breath Res; 2022 May; 16(3):. PubMed ID: 35453137
[TBL] [Abstract][Full Text] [Related]
4. Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant.
Sharma R; Zang W; Tabartehfarahani A; Lam A; Huang X; Sivakumar AD; Thota C; Yang S; Dickson RP; Sjoding MW; Bisco E; Mahmood CC; Diaz KM; Sautter N; Ansari S; Ward KR; Fan X
JAMA Netw Open; 2023 Feb; 6(2):e230982. PubMed ID: 36853606
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
6. Machine learning enabled detection of COVID-19 pneumonia using exhaled breath analysis: a proof-of-concept study.
Cusack RP; Larracy R; Morrell CB; Ranjbar M; Le Roux J; Whetstone CE; Boudreau M; Poitras PF; Srinathan T; Cheng E; Howie K; Obminski C; O'Shea T; Kruisselbrink RJ; Ho T; Scheme E; Graham S; Beydaghyan G; Gavreau GM; Duong M
J Breath Res; 2024 Mar; 18(2):. PubMed ID: 38382095
[TBL] [Abstract][Full Text] [Related]
7. Breath of Health: spectroscopy-based breath test for the detection of SARS-CoV-2.
Padawer D; Qadan A; Karameh M; Darawshy F; Laor A; Banker S; Fridlender ZG
Infect Dis (Lond); 2024 May; 56(5):376-383. PubMed ID: 38424673
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive meta-analysis and systematic review of breath analysis in detection of COVID-19 through Volatile organic compounds.
Long GA; Xu Q; Sunkara J; Woodbury R; Brown K; Huang JJ; Xie Z; Chen X; Fu XA; Huang J
Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116309. PubMed ID: 38692202
[TBL] [Abstract][Full Text] [Related]
9. Breath collection protocol for SARS-CoV-2 testing in an ambulatory setting.
Myers R; Ruskiewicz D; Meister A; Sukhinder AK; Bartolomeu C; Thomas P; Lam S
J Breath Res; 2022 Mar; 16(2):. PubMed ID: 35073523
[No Abstract] [Full Text] [Related]
10. Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.
Gupta RK; Rosenheim J; Bell LC; Chandran A; Guerra-Assuncao JA; Pollara G; Whelan M; Artico J; Joy G; Kurdi H; Altmann DM; Boyton RJ; Maini MK; McKnight A; Lambourne J; Cutino-Moguel T; Manisty C; Treibel TA; Moon JC; Chain BM; Noursadeghi M;
Lancet Microbe; 2021 Oct; 2(10):e508-e517. PubMed ID: 34250515
[TBL] [Abstract][Full Text] [Related]
11. A feasibility study of Covid-19 detection using breath analysis by high-pressure photon ionization time-of-flight mass spectrometry.
Zhang P; Ren T; Chen H; Li Q; He M; Feng Y; Wang L; Huang T; Yuan J; Deng G; Lu H
J Breath Res; 2022 Sep; 16(4):. PubMed ID: 36052728
[TBL] [Abstract][Full Text] [Related]
12. Detection of SARS-CoV-2 infection by exhaled breath spectral analysis: Introducing a ready-to-use point-of-care mass screening method.
Shlomo IB; Frankenthal H; Laor A; Greenhut AK
EClinicalMedicine; 2022 Mar; 45():101308. PubMed ID: 35224472
[TBL] [Abstract][Full Text] [Related]
13. A multiple-method comparative study using GC-MS, AMDIS and in-house-built software for the detection and identification of "unknown" volatile organic compounds in breath.
Marder D; Tzanani N; Baratz A; Drug E; Prihed H; Weiss S; Ben-Chetrit E; Eichel R; Dagan S; Yishai Aviram L
J Mass Spectrom; 2021 Oct; 56(10):e4782. PubMed ID: 34523187
[TBL] [Abstract][Full Text] [Related]
14. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
[TBL] [Abstract][Full Text] [Related]
15. The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.
Subali AD; Wiyono L; Yusuf M; Zaky MFA
Diagn Microbiol Infect Dis; 2022 Feb; 102(2):115589. PubMed ID: 34879323
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of chemical breath-prints through olfactory technology for the discrimination between SARS-CoV-2 infected patients and controls.
Rodríguez-Aguilar M; Díaz de León-Martínez L; Zamora-Mendoza BN; Comas-García A; Guerra Palomares SE; García-Sepúlveda CA; Alcántara-Quintana LE; Díaz-Barriga F; Flores-Ramírez R
Clin Chim Acta; 2021 Aug; 519():126-132. PubMed ID: 33901429
[TBL] [Abstract][Full Text] [Related]
17. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.
Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302
[TBL] [Abstract][Full Text] [Related]
18. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
19. Stability of volatile organic compounds in sorbent tubes following SARS-CoV-2 inactivation procedures.
Lomonaco T; Salvo P; Ghimenti S; Biagini D; Vivaldi F; Bonini A; Fuoco R; Di Francesco F
J Breath Res; 2021 Apr; 15(3):. PubMed ID: 33752195
[TBL] [Abstract][Full Text] [Related]
20. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study.
Pallett SJC; Rayment M; Patel A; Fitzgerald-Smith SAM; Denny SJ; Charani E; Mai AL; Gilmour KC; Hatcher J; Scott C; Randell P; Mughal N; Jones R; Moore LSP; Davies GW
Lancet Respir Med; 2020 Sep; 8(9):885-894. PubMed ID: 32717210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
